Hot Features
プレミアム
Nuvalent Inc (NUVL)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Ms. Alexandra BalcomCFO & Treasurer | -11.43k | 1.05M | Derivative Exercise and Sale | 6.89 - 103.84 | 85.53k | - |
| 2026-05-28 | Ms. Darlene NociChief Development Officer | -5.50k | 439.75k | Derivative Exercise and Sale | 27.85 - 109.76 | 17.02k | - |
| 2026-05-28 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5.50k | 555.21k | Derivative Exercise and Sale | 6.89 - 109.30 | 18.53k | - |
| 2026-05-04 | Dr. James R. PorterCEO, President & Director | -30.00k | 2.48M | Derivative Exercise and Sale | 18.93 - 102.88 | 203.53k | - |
| 2026-05-01 | Ms. Alexandra BalcomCFO & Treasurer | -11.43k | 1.09M | Derivative Exercise and Sale | 1.08 - 99.97 | 85.53k | - |
| 2026-04-30 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5.50k | 507.80k | Derivative Exercise and Sale | 6.89 - 99.57 | 18.53k | - |
| 2026-04-29 | Ms. Darlene NociChief Development Officer | -5.50k | 394.35k | Derivative Exercise and Sale | 27.85 - 101.17 | 17.02k | - |
| 2026-04-09 | Dr. Henry PelishChief Scientific Officer | -3.09k | 237.02k | Derivative Exercise and Sale | 27.85 - 105.00 | 20.14k | - |
| 2026-04-06 | Dr. James R. PorterCEO, President & Director | -30.00k | 2.40M | Derivative Exercise and Sale | 18.93 - 105.60 | 203.53k | - |
| 2026-04-01 | Ms. Alexandra BalcomCFO & Treasurer | -11.43k | 1.19M | Derivative Exercise and Sale | 1.08 - 106.18 | 85.53k | - |
| 2026-03-30 | Ms. Darlene NociChief Development Officer | -5.50k | 384.77k | Derivative Exercise and Sale | 27.85 - 98.13 | 17.02k | - |
| 2026-03-26 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5.50k | 505.10k | Derivative Exercise and Sale | 6.89 - 99.46 | 18.53k | - |
| 2026-03-25 | Ms. Alexandra BalcomCFO & Treasurer | -13.70k | 1.37M | Automatic Disposition | 100.16 | 44.43k | -23.57% |
| 2026-03-24 | Ms. Alexandra BalcomCFO & Treasurer | -11.43k | 1.08M | Derivative Exercise and Sale | 1.08 - 96.50 | 44.43k | - |
| 2026-03-12 | Dr. Henry PelishChief Scientific Officer | -17.32k | 1.15M | Derivative Exercise and Sale | 18.93 - 97.79 | 20.14k | - |
| 2026-03-12 | Dr. Henry PelishChief Scientific Officer | -17.78k | 1.75M | Automatic Disposition | 97.79 - 99.71 | 20.14k | -46.90% |
| 2026-03-06 | Dr. James R. PorterCEO, President & Director | -30.00k | 2.13M | Derivative Exercise and Sale | 27.85 - 100.19 | 203.53k | - |
| 2026-02-26 | Ms. Darlene NociChief Development Officer | -5.50k | 413.51k | Derivative Exercise and Sale | 27.85 - 104.25 | 17.02k | - |
| 2026-02-26 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5.50k | 528.89k | Derivative Exercise and Sale | 6.89 - 103.96 | 18.53k | - |
| 2026-01-29 | Ms. Darlene NociChief Development Officer | -5.50k | 408.25k | Derivative Exercise and Sale | 27.85 - 103.39 | 17.02k | - |
| 2026-01-21 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -15.00k | 1.23M | Derivative Exercise and Sale | 27.85 - 110.16 | 18.53k | - |
| 2026-01-05 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -6.95k | 676.16k | 売り | 96.06 - 98.52 | 18.53k | -27.28% |
| 2026-01-05 | Ms. Darlene NociChief Development Officer | -7.42k | 721.32k | 売り | 96.06 - 98.52 | 17.02k | -30.36% |
| 2026-01-05 | Dr. Henry PelishChief Scientific Officer | -5.16k | 501.75k | 売り | 96.06 - 98.52 | 24.46k | -17.42% |
| 2026-01-05 | Ms. Alexandra BalcomCFO & Treasurer | -7.42k | 721.32k | 売り | 96.06 - 98.52 | 58.13k | -11.32% |
| 2026-01-05 | Dr. Christopher D. TurnerChief Medical Officer | -7.42k | 721.32k | 売り | 96.06 - 98.52 | 31.53k | -19.04% |
| 2026-01-05 | Dr. James R. PorterCEO, President & Director | -27.43k | 2.67M | 売り | 96.06 - 98.52 | 203.53k | -11.88% |
| 2026-01-02 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -10.00k | 815.81k | Derivative Exercise and Sale | 18.93 - 101.47 | 8.14k | - |
| 2025-12-30 | Ms. Darlene NociChief Development Officer | -4.00k | 288.78k | Derivative Exercise and Sale | 27.85 - 101.22 | 48.03k | - |
| 2025-12-22 | Ms. Alexandra BalcomCFO & Treasurer | 34.50k | 37.26k | Derivative Exercise and Retained Stock | 1.08 | 48.20k | 251.82% |
| 2025-12-22 | Dr. Henry PelishChief Scientific Officer | 5.09k | 5.49k | Derivative Exercise and Retained Stock | 1.08 | 30.10k | 20.33% |
| 2025-12-19 | Dr. James R. PorterCEO, President & Director | 57.00k | 37.05k | Derivative Exercise and Retained Stock | 0.65 | 174.61k | 48.46% |
| 2025-12-08 | Ms. Alexandra BalcomCFO & Treasurer | -7.08k | 781.54k | Automatic Disposition | 110.31 - 111.32 | 13.70k | -34.08% |
| 2025-11-28 | Ms. Darlene NociChief Development Officer | -4.00k | 322.92k | Derivative Exercise and Sale | 27.85 - 108.72 | 48.03k | - |
| 2025-11-24 | Prof. Matthew D. Shairインサイダー | -7.50k | 820.27k | Automatic Disposition | 107.70 - 110.42 | 1.58M | -0.47% |
| 2025-11-24 | Deerfield Management Company, L.P.法人 | -742.57k | 70.87M | 売り | 95.45 | 17.25M | -4.13% |
| 2025-11-17 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -24.20k | 2.39M | Derivative Exercise and Sale | 6.89 - 107.04 | 8.14k | - |
| 2025-11-17 | Ms. Alexandra BalcomCFO & Treasurer | -20.73k | 1.02M | Derivative Exercise and Sale | 6.89 - 104.54 | 20.78k | - |
| 2025-10-30 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -21.80k | 2.10M | Derivative Exercise and Sale | 6.89 - 104.78 | 8.14k | - |
| 2025-10-30 | Ms. Darlene NociChief Development Officer | -4.00k | 300.26k | Derivative Exercise and Sale | 27.85 - 104.58 | 48.03k | - |
| 2025-10-27 | Prof. Matthew D. Shairインサイダー | -60.00k | 6.02M | Automatic Disposition | 100.23 - 100.27 | 1.58M | -3.65% |
| 2025-10-20 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -5.00k | 440.10k | Derivative Exercise and Sale | 6.89 - 94.91 | 8.14k | - |
| 2025-10-16 | Dr. James R. PorterCEO, President & Director | -27.00k | 1.94M | Derivative Exercise and Sale | 18.93 - 92.63 | 117.61k | - |
| 2025-10-15 | Dr. Henry PelishChief Scientific Officer | -14.21k | 780.76k | Derivative Exercise and Sale | 18.93 - 90.04 | 25.01k | - |
| 2025-10-15 | Ms. Deborah Ann MillerChief Legal Officer & Secretary | -28.00k | 2.35M | Derivative Exercise and Sale | 6.89 - 92.50 | 8.14k | - |
| 2025-10-15 | Ms. Alexandra BalcomCFO & Treasurer | -1.68k | 112.16k | Derivative Exercise and Sale | 18.93 - 85.57 | 20.78k | - |
| 2025-10-13 | Dr. Henry PelishChief Scientific Officer | -10.07k | 554.22k | Derivative Exercise and Sale | 18.93 - 89.81 | 25.01k | - |
| 2025-10-13 | Ms. Alexandra BalcomCFO & Treasurer | -40.00k | 2.82M | Derivative Exercise and Sale | 6.89 - 89.22 | 20.78k | - |
| 2025-10-01 | Ms. Alexandra BalcomCFO & Treasurer | -20.00k | 1.53M | Derivative Exercise and Sale | 6.89 - 86.37 | 20.78k | - |
| 2025-09-29 | Ms. Alexandra BalcomCFO & Treasurer | -27.59k | 2.16M | Derivative Exercise and Sale | 6.89 - 85.06 | 20.78k | - |
| 2025-09-29 | Ms. Darlene NociChief Development Officer | -4.00k | 220.89k | Derivative Exercise and Sale | 27.85 - 84.92 | 7.08k | - |
| 2025-09-15 | Dr. James R. PorterCEO, President & Director | -27.00k | 1.62M | Derivative Exercise and Sale | 18.93 - 80.12 | 117.61k | - |
| 2025-09-10 | Dr. Henry PelishChief Scientific Officer | -3.73k | 193.29k | Derivative Exercise and Sale | 18.93 - 78.83 | 25.01k | - |
| 2025-08-29 | Dr. Henry PelishChief Scientific Officer | 5.01k | 4.99k | Derivative Exercise and Retained Stock | 0.87 - 1.08 | 38.48k | 14.96% |
| 2025-08-25 | Ms. Darlene NociChief Development Officer | -4.00k | 187.09k | Derivative Exercise and Sale | 27.85 - 75.63 | 7.08k | - |
| 2025-08-15 | Dr. James R. PorterCEO, President & Director | -27.00k | 1.53M | Derivative Exercise and Sale | 18.93 - 76.90 | 117.61k | - |
| 2025-08-07 | Dr. Henry PelishChief Scientific Officer | -5.50k | 259.26k | Derivative Exercise and Sale | 18.93 - 74.85 | 20.01k | - |
| 2025-07-30 | Ms. Darlene NociChief Development Officer | -4.00k | 210.04k | Derivative Exercise and Sale | 27.85 - 80.36 | 7.08k | - |
| 2025-07-15 | Ms. Alexandra BalcomCFO & Treasurer | -20.00k | 1.31M | Derivative Exercise and Sale | 18.93 - 85.48 | 20.78k | - |
| 2025-07-15 | Dr. James R. PorterCEO, President & Director | -27.00k | 1.71M | Derivative Exercise and Sale | 18.93 - 84.53 | 117.61k | - |
| 2025-07-10 | Dr. Henry PelishChief Scientific Officer | -5.50k | 281.78k | Derivative Exercise and Sale | 18.93 - 80.92 | 20.01k | - |
| 2025-07-09 | Dr. Henry PelishChief Scientific Officer | -2.15k | 174.08k | Automatic Disposition | 81.08 - 81.90 | 20.01k | -9.68% |
| 2025-06-27 | Ms. Alexandra BalcomCFO & Treasurer | -20.00k | 1.22M | Derivative Exercise and Sale | 18.93 - 80.02 | 20.78k | - |
| 2025-06-26 | Ms. Darlene NociChief Development Officer | -4.00k | 203.43k | Derivative Exercise and Sale | 27.85 - 79.15 | 7.08k | - |
| 2025-06-25 | Dr. Henry PelishChief Scientific Officer | -10.80k | 551.90k | Derivative Exercise and Sale | 27.85 - 79.92 | 17.78k | - |
| 2025-06-16 | Dr. James R. PorterCEO, President & Director | -27.00k | 1.33M | Derivative Exercise and Sale | 27.85 - 78.22 | 117.61k | - |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
